Poly Medicure is one of the world’s largest manufacturers of medical devices and has recently received Medical Device Regulation (MDR) validation for 54 of its products across diverse specialties such as infusion therapy, surgery & wound care....
Empagliflozin, a well-known SGLT2 inhibitor, has been introduced in India by Glenmark Pharmaceuticals Ltd. (Glenmark), a multinational pharmaceutical business that prioritizes research.
India expects almost ?17,000 crore for the pharmaceutical research and development (R&D) in the period up to FY28, focusing on...
Zydus Lifesciences Limited, a global innovation-driven life sciences company, began exclusive negotiations to acquire an 85.6 percent stake in Amplitude Surgical, whereby the deal is proposed by...
Capitalizing on demographic factors, technological advancements, and increasing demand for quality and preventive care, the healthcare sector of...
Syngene International acquired its first biologics manufacturing site in the United States at $36.5 million, a major expansion in the...
The Department of Pharmaceuticals has invited expression of interest from entities for the purpose of project funding under the Promotion...
A number of Indian pharmaceutical companies are getting ready to release much more affordable generic versions of the diabetes medication empagliflozin. The action comes after Boehringer Ingelheim's patent expired, according to the sources.
Zydus Lifesciences Limited has acquired final permission from the US Food and Drug Administration (USFDA) to manufacture 2% ketoconazole shampoo. According to the company's release today.
Glenmark Pharmaceuticals have a presence in more than 80 countries, and the US market will see the introduction of Polyethylene Glycol 3350 Powder for Solution as an over-the-counter product...
, CDSCO.jpg)
